30/03/2026
Artificial intelligence is redefining how we understand and predict health, moving beyond reactive treatment towards earlier insights, action, and prevention at scale. By interpreting biological signals across populations, AI is using data-led insights to move from diagnosis to foresight.
Companies such as Group 42 are at the centre of this shift, combining AI with integrated data infrastructure and responsible governance to decode the language of biology and identify risk before it becomes illness.
At the forefront of this approach, Abu Dhabi is operationalising AI and data systems at scale to advance a new standard for what population health systems are built to do.